Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Advanced Malignant Neoplasm 1

Interventions

Polymerase Chain Reaction 4Selenium 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vitamin E 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Melphalan 2Light Coagulation 2Cytogenetic Analysis 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Busulfan 2alpha-Tocopherol 1Watchful Waiting 1Vaginal Smears 1Soybean Proteins 1Rosuvastatin Calcium 1Paclitaxel 1Moxifloxacin 1Morphine 1Microarray Analysis 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Genetic Testing × Other neoplasm × Clear all
NCT02823652 2024-02-28

Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer

Eastern Cooperative Oncology Group

Phase NA Completed
601 enrolled 16 charts
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡